Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,588 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ubap1 knock-in mice reproduced the phenotype of SPG80.
Shimozono K, Nan H, Hata T, Saito K, Kim YJ, Nagatomo H, Ohtsuka T, Koizumi S, Takiyama Y. Shimozono K, et al. Among authors: kim yj. J Hum Genet. 2022 Dec;67(12):679-686. doi: 10.1038/s10038-022-01073-6. Epub 2022 Aug 12. J Hum Genet. 2022. PMID: 35962060 Free PMC article.
RFC1 repeat expansion in Japanese patients with late-onset cerebellar ataxia.
Tsuchiya M, Nan H, Koh K, Ichinose Y, Gao L, Shimozono K, Hata T, Kim YJ, Ohtsuka T, Cortese A, Takiyama Y. Tsuchiya M, et al. Among authors: kim yj. J Hum Genet. 2020 Dec;65(12):1143-1147. doi: 10.1038/s10038-020-0807-x. Epub 2020 Jul 21. J Hum Genet. 2020. PMID: 32694621
A Novel Heterozygous Missense Variant in the CIAO1 Gene in a Family with Alzheimer's Disease: The Val67Ile Variant Promotes the Interaction of CIAO1 and Amyloid-β Protein Precursor.
Nan H, Kim YJ, Tsuchiya M, Fukao T, Hara N, Hagihara A, Nishioka K, Hattori N, Hara N, Ikeuchi T, Ohtsuka T, Takiyama Y. Nan H, et al. Among authors: kim yj. J Alzheimers Dis. 2021;84(2):599-605. doi: 10.3233/JAD-210706. J Alzheimers Dis. 2021. PMID: 34569959 Free PMC article.
Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms.
Shima Y, Sasagawa S, Ota N, Oyama R, Tanaka M, Kubota-Sakashita M, Kawakami H, Kobayashi M, Takubo N, Ozeki AN, Sun X, Kim YJ, Kamatani Y, Matsuda K, Maejima K, Fujita M, Noda K, Kamiyama H, Tanikawa R, Nagane M, Shibahara J, Tanaka T, Rikitake Y, Mataga N, Takahashi S, Kosaki K, Okano H, Furihata T, Nakaki R, Akimitsu N, Wada Y, Ohtsuka T, Kurihara H, Kamiguchi H, Okabe S, Nakafuku M, Kato T, Nakagawa H, Saito N, Nakatomi H. Shima Y, et al. Among authors: kim yj. Sci Transl Med. 2023 Jun 14;15(700):eabq7721. doi: 10.1126/scitranslmed.abq7721. Epub 2023 Jun 14. Sci Transl Med. 2023. PMID: 37315111
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM).
Park S, Baldry R, Jung HA, Sun JM, Lee SH, Ahn JS, Kim YJ, Lee Y, Kim DW, Kim SW, Lee KH, Lee WJ, Choi JW, Chong K, Lee JI, Gwon SH, Son NH, Ahn MJ. Park S, et al. Among authors: kim yj. J Clin Oncol. 2024 Jun 3:JCO2400708. doi: 10.1200/JCO.24.00708. Online ahead of print. J Clin Oncol. 2024. PMID: 38828959
12,588 results
You have reached the last available page of results. Please see the User Guide for more information.